Proteomics integrated with Escherichia coli vector-based vaccines and antigen microarrays reveals the immunogenicity of a surface sialidase-like protein of Propionibacterium acnes

Proteomics - Clinical Applications

Volumn 2, Issue 9, 2008, Pages 1234-1245

  Huang, Cheng Po ^a,b   Liu, Yu Tsueng ^a   Nakatsuji, Teruaki ^c   Shi, Yang ^d   Gallo, Richard R ^c   Lin, Shwu Bin ^b   Huang, Chun Ming ^a,c,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BURNHAM INSTITUTE   (United States)

^e LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Antigen microarray; Immunogenicity; Propionibacterium acnes; Sialidase like protein; Vector based vaccine

Indexed keywords

RECOMBINANT PROTEIN; SIALIDASE; TETANUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TARGETING; PROTEOMICS; ULTRAVIOLET IRRADIATION; VACCINE PRODUCTION;

ESCHERICHIA COLI; MUS; PROPIONIBACTERIUM ACNES;

EID: 53549112756     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780103     Document Type: Article

References (48)

1. Chich, J. F., Schaeffer, B., Bouin, A. P., Mouthon, F. et al., Prion infection-impaired functional blocks identified by proteomics enlighten the targets and the curing pathways of an anti-prion drug. Biochim. Biophys. Acta 2007, 1774, 154-167.
2. Hess, J. L., Blazer, L., Romer, T., Faber, L. et al., Immunoproteomics. J. Chromatogr. B Analyt. Techno.l Biomed. Life Sci. 2005, 815, 65-75.
3. Zenteno-Cuevas, R., Huerta-Yepez, S., Reyes-Leyva, J., Hernández-Jáuregui, P. et al., Identification of potential B cell epitope determinants by computer techniques, in hemagglutinin-neuraminidase from the porcine rubulavirus La Piedad Michoacan. Viral. Immunol. 2007, 20, 250-260.
4. Ferreira-da-Cruz Mde, F., Giovanni-de-Simone, S., Banic, D. M., Canto-Cavalheiro, M. et al., Can software be used to predict antigenic regions in Plasmodium falciparum peptides? Parasite Immunol. 1996, 18, 159-161.
5. Wilson, R. A., Curwen, R. S., Braschi, S., Hall, S. L. et al., From genomes to vaccines via the proteome. Mem. Inst. Oswaldo Cruz 2004, 99, 45-50.
6. Zhang, J., Shi, Z., Kong, F.K., Jex, E. et al., Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity. Infect. Immun. 2006, 74, 3607-3617.
7. Liu, Y. T., Lin, S. B., Huang, C. P., Huang, C. M. A novel immunogenic spore coat-associated protein in Bacillus anthracis: characterization via proteomics approaches and a vector-based vaccine system. Protein Expr.Purif. 2008, 57, 72-80.
8. Lauvau, G., Vijh, S., Kong, P., Horng, T. et al., Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 2001, 294, 1735-1739.
9. Brockstedt, D. G., Bahjat, K. S., Giedlin, M. A., Liu, W. et al., Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nat. Med. 2005, 11, 853-860.
10. Datta, S. K., Okamoto, S., Hayashi, T., Shin, S. S. et al., Vaccination with irradiated Listeria induces protective T cell immunity. Immunity 2006, 25, 143-152.
11. Meadows, M. Strategies to reduce medication errors. How the FDA is working to improve medication safety and what you can do to help. FDA. Consum. 2003, 37, 20-27.
12. Predki, P. F., Mattoon, D., Bangham, R., Schweitzer, B., Michaud, G., Protein microarrays: a new tool for profiling antibody cross-reactivity. Hum. Antibodies 2005, 14, 7-15.
13. Bruggemann, H., Henne, A., Hoster, F., Liesegang, H. et al., The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004, 305, 671-673.
14. Perry, A. L., Lambert, P. A. Propionibacterium acnes. Lett. Appl. Microbiol. 2006, 42, 185-188.
15. Johansson, B. E., Brett, I. C. Changing perspective on immunization against influenza. Vaccine 2007, 25, 3062-3065.
16. Tai, S. S., Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit. Rev. Microbiol. 2006, 32, 39-53.
17. Makoff, A. J., Oxer, M.D., Romanos, M. A., Fairweather, N. F., Ballantine, S., Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucleic Acids Res. 1989, 17, 10191-10202.
18. Studier, F. W., Rosenberg, A. H., Dunn, J. J., Dubendorff, J. W., Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990, 185, 60-89.
19. Zhou, J. C., Yi, X. Y., Kalinna, B. H., McManus, D. P., Expression and purification of recombinant Schistosoma japonicum paramyosin. Hunan Yi. Ke. Da. Xue. Xue. Bao. 2000, 25, 106-108.
20. Huang, C. M., Ananthaswamy, H. N., Barnes, S., Ma, Y. et al., Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses. Proteomic. 2006, 6, 6107-6116.
21. Huang, C. M., Wang, C. C., Kawai, M., Barnes, S., Elmets, C. A., Surfactant sodium lauryl sulfate enhances skin vaccination: molecular characterization via a novel technique using ultrafiltration capillaries and mass spectrometric proteomics. Mol. Cell. Proteomics 2006, 5, 523-532.
22. Eisen, M. B., Brown, P. O., DNA arrays for analysis of gene expression. Methods Enzymol. 1999, 303, 179-205.
23. Wang, D., Urisman, A., Liu, Y. T., Springer, M. et al., Viral discovery and sequence recovery using DNA microarrays. PLoS. Biol. 2003, 1, E2.
24. Dentovskaia, S. V., Shaihutdinov, R. Z., Knirel', I., Ivanov, S. A., Anisimov, A. P., Generation of vaccine strains of gram-negative bacteria with reduced adverse reactions. Gen. Mikrobiol Virusol. 2006, 2, 3-8.
25. Detmer, A., Glenting, J., Live bacterial vaccines - a review and identification of potential hazards Microb. Cell Fact. 2006, 5, 23-24.
26. Blander, J. M., Medzhitov, R., Regulation of phagosome maturation by signals from toll-like receptors. Science 2004, 304, 1014-1018.
27. Gouy, M., Gautier, C., Codon usage in bacteria: correlation with gene expressivity. Nucleic Acids Res. 1982, 10, 7055-7074.
28. Tsang, V. C., Wilkins, P. P., Immunodiagnosis of schistosomiasis. Screen with FAST-ELISA and confirm with immunoblot. Clin. Lab Med. 1991, 11, 1029-1039.
29. Shomaker, T. S., Ward, K., Microarray technology in biomedical research. Hawaii Med. J. 2006, 65, 253-256.
30. Kharat, A. S., Tomasz, A., Inactivation of the srtA gene affects localization of surface proteins and decreases adhesion of Streptococcus pneumoniae to human pharyngeal cells in vitro. Infect. Immun., 2003, 71, 2758-2765.
31. Kleineidam, R. G., Kruse, S., Roggentin, P., Schauer, R. Elucidation of the role of functional amino acid residues of the small sialidase from Clostridium perfringens by site-directed mutagenesis. Biol. Chem. 2001, 382, 313-319.
32. Basal, E., Jain, A., Kaushal, G. P., Antibody response to crude cell lysate of Propionibacterium acnes and induction of proinflammatory cytokines in patients with acne and normal healthy subjects. J. Microbiol. 2004, 42, 117-125.
33. Larsen, M. R., Trelle, M. B., Thingholm, T. E., Jensen, O. N., Analysis of posttranslational modifications of proteins by tandem mass spectrometry. Biotechniques 2006, 40, 790-798.
34. Holmgren, J., Czerkinsky, C., Mucosal immunity and vaccines. Nat. Med. 2005, 11, S45-S53.
35. Singh, M., Srivastava, I., Advances in vaccine adjuvants for infectious diseases. Curr. HIV Res. 2003, 1, 309-320.
36. O'Hagan, D. T., MacKichan, M. L., Singh, M., Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng. 2001, 18, 69-85.
37. Burgio, M. R., Bennett, P. M., Koretz, J. F., Heat-induced quaternary transitions in hetero- and homo-polymers of alpha-crystallin. Mol. Vis. 2001, 7, 228-233.
38. Hijnen, W. A., Beerendonk, E. F., Medema, G. J., Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo) cysts in water: a review. Water Res. 2006, 40, 3-22.
39. Frank, R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 2002, 267, 13-26.
40. Every, A. L., Kramer, D. R., Mannering, S. I., Lew, A. M., Harrison, L. C., Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes. J. Immunol. 2006, 176, 4608-4615.
41. Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L. et al., Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine 2002, 20, 2752-2763.
42. Meissner, H. C., Influenza vaccines: a pediatric perspective. Curr. Opin. Pediatr. 2007, 19, 58-63.
43. Garmise, R. J., Staats, H. F., Hickey, A. J., Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. AAPS PharmSciTech. 2007, 8, E81.
44. Tylewska-Wierzbanowska, S., Chmielewski, T., Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and Western blot in comparison with PCR and culture methods. Wien. Klin. Wochenschr. 2002, 114, 601-605.
45. Neuman, D. V., Amara, R. R., Steinman, L., Utz, P. J. et al., Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen.J. Virol. 2003, 77, 11125-11138.
46. Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B. et al., Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002, 8, 295-301.
47. Winter, C., Schwegmann-Wessels, C., Cavanagh, D., Neumann, U., Herrler, G., Sialic acid is a receptor determinant for infection of cells by avian infectious bronchitis virus. J. Gen. Virol. 2006, 87, 1209-1216.
48. Nakatsuji, T., Liu, Y. T., Huang, C. P., Gallo, R.L., Huang, C. M., Vaccination targeting a surface sialidase of P. acnes: Implication for new treatment of acne vulgaris. PLoS ONE. 2008, 3, e1551.